Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy

Özkurt, Zülal; Kiki, H; EROL, SERPİL; Erdem, Fuat; YILMAZ, NEZİHA; Partak, M; Gundogdu, Mehmet; TAŞYARAN, MEHMET AKIN

doi:10.1016/j.jinf.2005.05.003

Makale Tam Makale Uluslararası 2006

Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy

Zülal Özkurt, H Kiki, SERPİL EROL, Fuat Erdem, NEZİHA YILMAZ, M Partak, Mehmet Gundogdu, MEHMET AKIN TAŞYARAN

The Journal of infection Cilt 52 · Sayı 3 · ss. 207–215 · 01.03.2006

DOI ile aç

Özet

Objectives: This study described the clinical features, factors affecting the outcome of this disease, risk factors, and efficacy of ribavirin therapy for CCHF patients in Eastern Turkey.

Anahtar kelimeler

risk factors Crimean-Congo Hemorrhagic Fever ribavirin

Atıf için künye

Özkurt, Z., Kiki, H., EROL, S., Erdem, F., YILMAZ, N., Partak, M., Gundogdu, M., & TAŞYARAN, M. A. (2006). Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. The Journal of infection, 52(3), 207–215. https://doi.org/10.1016/j.jinf.2005.05.003

BibTeX

@article{ozkurt2006-225470,
  author = {Özkurt, Zülal and Kiki, H and EROL, SERPİL and Erdem, Fuat and YILMAZ, NEZİHA and Partak, M and Gundogdu, Mehmet and TAŞYARAN, MEHMET AKIN},
  title = {Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy},
  journal = {The Journal of infection},
  year = {2006},
  volume = {52},
  number = {3},
  pages = {207--215},
  issn = {0163-4453},
  doi = {10.1016/j.jinf.2005.05.003},
  url = {https://akademik.atauni.edu.tr/yayinlar/225470-crimean-congo-hemorrhagic-fever-in-eastern-turkey-clinical-features-risk-factors}
}